자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There are few data regarding how exposure over time may affect a fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders such as hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of using them against the risks to the foetus. Physicians do not have the necessary data to make unequivocal recommendations, but they can provide information about the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not face an increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy and those Who Can Prescribe Adhd Medication For Adults had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was accurate and to minimize any bias.

However, the researchers' study had its limitations. Most important, they were unable to separate the effects of the medication from the disorder that is underlying. This makes it difficult for researchers to establish whether the few associations observed between the groups exposed were due to medication use, or if they were affected by comorbidities. The researchers did not look at the long-term effects for the offspring.

The study did find that infants whose mothers took ADHD medications during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications during early pregnancies can be offset by greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should speak with their patients about this issue and, if possible, help them improve coping skills which may reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether to continue or end treatment during pregnancy is one that doctors are having to face. These decisions are usually taken without clear and authoritative evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other doctors and the research on the topic.

Particularly, the subject of potential risks for the baby can be a challenge. Many of the studies on this issue are based on observations rather than controlled research and their conclusions are often contradictory. The majority of studies restrict their analysis to live-births, which could underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study presented in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the risk of certain birth defects, others have found no such relationship and the majority of studies demonstrate a neutral or slightly negative impact. Therefore, a careful risk/benefit analysis is required in every instance.

For a lot of women with ADHD who suffer from ADHD, the decision to discontinue medication is difficult if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. In addition, a decrease in medication can affect the ability to complete work-related tasks and safely drive which are essential aspects of daily life for many people with ADHD.

She recommends women who are unsure about whether to continue or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. It can also help women feel more confident in her decision. It is important to note that some medications are able to be absorbed through the placenta therefore, if a patient decides to stop her adhd medication names medication during pregnancy and breastfeeding, she must be aware that the effects of the medication could be passed on to the baby.

Risk of Birth Defects

As the use and abuse of liquid adhd medication uk medication to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Researchers used two massive data sets to examine more than 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to adhd medication intuniv medications was associated with an increased risk of certain heart defects, such as ventriculo-septal defect (VSD).

The authors of the study found no link between early use of medication and congenital abnormalities such as facial clefting or club foot. The results are in agreement with previous studies which showed an insignificant, but small increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their ADHD medications.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth, have a low Apgar after birth and have a baby that needed help breathing at birth. The researchers of the study were unable to eliminate bias due to selection because they restricted the study to women without other medical conditions that might have contributed to the findings.

Researchers hope their research will provide doctors with information when they see pregnant women. They suggest that although a discussion of the risks and benefits is crucial, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to think about, it isn't advised because of the high incidence of depression and other mental problems in women who are expecting or recently gave birth. Further, the research suggests that women who choose to stop taking their medications are more likely to have a difficult time adjusting to life without them following the baby's arrival.

Nursing

It can a general practitioner prescribe adhd medication be overwhelming becoming a mother. Women who suffer from ADHD may face a lot of challenges when they have to manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. As such, many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications is absorbed through breast milk at a low level. However, the amount of exposure to medications by the newborn may differ based on dosage, how often it is administered and the time of the day it is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't completely comprehended.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult decision for the patient, who must balance the benefits of keeping her medication with the potential risks to the foetus. Until more information becomes available, GPs may inquire about pregnant patients whether they have an history of ADHD or if they are planning to take medication during the perinatal stage.

A increasing number of studies have proven that women can continue their ADHD medication during pregnancy and breastfeeding. In response, an increasing number of patients are opting to do this. They have discovered, in consultation with their physicians that the benefits of continuing their current medication outweigh risk.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons of continuing treatment. This includes non prescription adhd medication-pharmacological methods. Psychoeducation is also required to help pregnant people with ADHD recognize their symptoms and the root cause, learn about available treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. Pregnancy counselling should include the discussion of a plan for management for both the mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.